Hosted on MSN1mon
FDA accepts Sobi’s Gamifant application for HLH/MAS treatment
Sobi chief medical officer and research and development head Lydia Abad-Franch stated: “HLH/MAS in Still’s disease is a serious and potentially fatal complication where patients can experience ...
Baby Meabh ended up in ICU after catching cold, we’re living a nightmare as she fights for life after rare diagnosis
A DUBLIN family has told how they are “living a nightmare” after their baby girl ended up in ICU after catching a cold. At ...
Pharmabiz1mon
US FDA grants priority review to Sobi’s sBLA for Gamifant for use in adult and paediatric patients with HLH/MAS in Still’s disease
HLH/MAS, a form of HLH, is a severe complication of rheumatic diseases, occurring most frequently in Still’s disease including systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still’s ...